Glycolytic metabolites, including glucose-6-phosphate, 3-phosphoglycerate, and fructose-6-phosphate, exhibited upregulated expression in high CBX2 and low CBX7 tumor samples. This evidence concerns the gene CBX2 and neoplasm.